title: Photorefractive keratectomy with mitomycin-C for the combined treatment of myopia and subepithelial infiltrates after epidemic keratoconjunctivitis.
abstract: OBJECTIVE
  To report the use of photorefractive keratectomy (PRK) with mitomycin-C (MMC) to treat concomitant myopia and visually significant infiltrates associated with epidemic keratoconjunctivitis (EKC).
  
  
  METHODS
  Ophthalmic Consultants of Long Island, Nassau University, Long Island, New York, USA.
  
  
  METHODS
  Interventional case series.
  
  
  METHODS
  Consecutive patients with myopia and recalcitrant subepithelial infiltrates after EKC were treated with custom wavefront PRK (Visx S4 IR) and MMC with a target of emmetropia in all cases.
  
  
  RESULTS
  The study evaluated 6 eyes of 3 patients. One year after treatment, all eyes attained an uncorrected distance visual acuity of 20/20 or better. There was no recurrence of infiltrates within the ablation zone in any eye.
  
  
  CONCLUSIONS
  The use of topical MMC in conjunction with PRK to treat subepithelial infiltrates due to EKC provided good visual and refractive results.
authors.affiliation: Ophthalmic Consultants of Long Island, Rockville Centre, New York, USA.
authors.forename: David
authors.initials: D
authors.lastname: Alevi
authors.forename: Allon
authors.initials: A
authors.lastname: Barsam
authors.forename: Jonathan
authors.initials: J
authors.lastname: Kruh
authors.forename: Jessica
authors.initials: J
authors.lastname: Prince
authors.forename: Henry D
authors.initials: HD
authors.lastname: Perry
authors.forename: Eric D
authors.initials: ED
authors.lastname: Donnenfeld
mesh_terms: D057128:Aberrometry; D000256:Adenoviridae / Q000302:isolation & purification*; D000258:Adenovirus Infections, Human / Q000188:drug therapy / Q000503:physiopathology / Q000601:surgery / Q000628:therapy*; D000287:Administration, Topical; D000328:Adult; D000477:Alkylating Agents / Q000008:administration & dosage; D003131:Combined Modality Therapy; D003236:Conjunctivitis, Viral / Q000188:drug therapy / Q000503:physiopathology / Q000601:surgery / Q000628:therapy*; D003646:Debridement; D019573:Epithelium, Corneal / Q000821:virology*; D005260:Female; D006801:Humans; D054018:Lasers, Excimer / Q000627:therapeutic use; D008297:Male; D016685:Mitomycin / Q000008:administration & dosage*; D009216:Myopia / Q000188:drug therapy / Q000503:physiopathology / Q000601:surgery / Q000628:therapy*; D018903:Photorefractive Keratectomy; D014792:Visual Acuity / Q000502:physiology; D055815:Young Adult
chemical_list: D000477:Alkylating Agents; D016685:Mitomycin